To achieve this goal, we conducted transcriptome analysis using a next-generation sequencing platform and identified major facilitator superfamily domain containing 4 (MFSD4) as a candidate biomarker for hepatic metastasis of GC. This evidence concerns the gene SLC60A1 and gastric cancer.